DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ACTIVATED PROTEIN C
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ACTIVATED PROTEIN C
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIPENZOLATE BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PIPENZOLATE BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
JPX41DUS2B
Molecule Type:
Small molecule
Molecular Formula:
C22H28BrNO3
Molecular Weight:
434.37
AlogP:
3.09
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CYSTINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYSTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
48TCX9A1VT
Molecule Type:
Small molecule
Molecular Formula:
C6H12N2O4S2
Molecular Weight:
240.31
AlogP:
-0.81
PSA:
126.64
HBD:
4.0
HBA:
#RotB:
7.0
Source:
BERBERINE
4
Small molecule
Approved
Unknown
Unknown
Adenocarcinoma of Lung; Adenoma; Hyperlipidemia, Familial Combined; Non-alcoholic Fatty Liver Disease; Prediabetic State; Diabetes Mellitus, Type 2
Unknown
BERBERINE
×
Maximum Phase:
4
First Approval:
None
UNII:
0I8Y3P32UF
Molecule Type:
Small molecule
Molecular Formula:
C20H18NO4+
Molecular Weight:
336.37
AlogP:
3.1
PSA:
40.8
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ACTIVATED CHARCOAL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACTIVATED CHARCOAL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FENTICONAZOLE NITRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FENTICONAZOLE NITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
8V4JGC8YRF
Molecule Type:
Small molecule
Molecular Formula:
C24H21Cl2N3O4S
Molecular Weight:
518.42
AlogP:
7.3
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
8.0
Source:
SIPULEUCEL-T
4
Cell
Unknown
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Prostatic acid phosphatase binding agent
SIPULEUCEL-T
×
Maximum Phase:
4
First Approval:
None
UNII:
8Q622VDR18
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM
4
Small molecule
Approved
CANCER
INJECTION
Unknown
Unknown
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRIMONIDINE TARTRATE; BRINZOLAMIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BRIMONIDINE TARTRATE; BRINZOLAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODIDE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
IODIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ART-123
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
ART-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DROSPIRENONE; ESTRADIOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DROSPIRENONE; ESTRADIOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRISEOFULVIN, ULTRAMICROSIZE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
GRISEOFULVIN, ULTRAMICROSIZE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYANOCOBALAMIN CO 58
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYANOCOBALAMIN CO 58
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C63H89CoN14O14P
Molecular Weight:
1355.4
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CHOLINE ALFOSCERATE
4
Small molecule
Approved
Unknown
Unknown
Cognitive Dysfunction; Diabetes Mellitus, Type 2
Unknown
CHOLINE ALFOSCERATE
×
Maximum Phase:
4
First Approval:
None
UNII:
60M22SGW66
Molecule Type:
Small molecule
Molecular Formula:
C8H20NO6P
Molecular Weight:
257.22
AlogP:
-1.45
PSA:
99.05
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SODIUM FLUORIDE; TRICLOSAN
4
Combination
Approved
OTHER
DENTAL
Unknown
Unknown
SODIUM FLUORIDE; TRICLOSAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PATROL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
PATROL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LIDOCAINE; TETRACAINE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
LIDOCAINE; TETRACAINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRISEOFULVIN, MICROCRYSTALLINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
GRISEOFULVIN, MICROCRYSTALLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC 99M SULFUR COLLOID
4
Unknown
Approved
Unknown
Unknown
Cystic Fibrosis; Breast Neoplasms; Melanoma; Neoplasms
Diagnostic agent
TECHNETIUM TC 99M SULFUR COLLOID
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALPHANATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ALPHANATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATROPINE SULFATE; EDROPHONIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ATROPINE SULFATE; EDROPHONIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIUM IN-111 CHLORIDE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
INDIUM IN-111 CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IPRINDOLE
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Unknown
IPRINDOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
69U0IKR8FP
Molecule Type:
Small molecule
Molecular Formula:
C19H28N2
Molecular Weight:
284.45
AlogP:
4.25
PSA:
8.17
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBALT CHLORIDE CO-57; CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR
4
Combination
Approved
OTHER
N/A
Unknown
Unknown
COBALT CHLORIDE CO-57; CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENALAPRIL MALEATE; FELODIPINE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Unknown
Unknown
ENALAPRIL MALEATE; FELODIPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMOBARBITAL SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
AMOBARBITAL SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
G0313KNC7D
Molecule Type:
Small molecule
Molecular Formula:
C11H17N2NaO3
Molecular Weight:
248.26
AlogP:
1.39
PSA:
78.76
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PHOSPHORIC ACID
4
Small molecule
Approved
Unknown
Unknown
Familial Hypophosphatemic Rickets
Unknown
PHOSPHORIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
E4GA8884NN
Molecule Type:
Small molecule
Molecular Formula:
H3O4P
Molecular Weight:
97.99
AlogP:
-0.93
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
0.0
Source:
ESOMEPRAZOLE MAGNESIUM;NAPROXEN
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ESOMEPRAZOLE MAGNESIUM;NAPROXEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FAMOTIDINE; IBUPROFEN
4
Combination
Approved
MUSCULOSKELETAL
ORAL
Unknown
Unknown
FAMOTIDINE; IBUPROFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALCLOFENAC
4
Small molecule
Approved
Unknown
Unknown
Rheumatic Diseases
Cyclooxygenase-1 inhibitor
ALCLOFENAC
×
Maximum Phase:
4
First Approval:
None
UNII:
M9CP5H21N8
Molecule Type:
Small molecule
Molecular Formula:
C11H11ClO3
Molecular Weight:
226.66
AlogP:
2.53
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ACETOMENAPHTHONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACETOMENAPHTHONE
×
Maximum Phase:
4
First Approval:
None
UNII:
DWG8UZD9HT
Molecule Type:
Small molecule
Molecular Formula:
C15H14O4
Molecular Weight:
258.27
AlogP:
3.0
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KAD-1229
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
KAD-1229
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
286
287
288
289
290
291
292
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA